Pharmaceuticals

Viscosupplementation Market 2025–2029: Tracking 10.3% CAGR Toward $6.67 Billion in Revenue

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the viscosupplementation market from 2025–2034 with trusted insights from The Business Research Company

How Will The Viscosupplementation Market Size Evolve Between Now And 2029?

The viscosupplementation market size has seen substantial growth in recent years. It is anticipated to increase from $4.1 billion in 2024 to $4.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.8%. This historical expansion can be attributed to factors like an aging population, rising obesity rates, enhanced insurance coverage, growing awareness, patient preference, and an increase in osteoarthritis cases.

The viscosupplementation market size is anticipated to experience substantial expansion over the upcoming years. It is projected to achieve $6.67 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.3%. This growth during the forecast period can be attributed to factors such as regulatory support, alternative payment models, increased healthcare expenditure, ongoing research and development, and the expansion of indications. Significant trends expected in this period encompass outcome-based payment models, initiatives for patient education, advancements in biomarker development, research into gene therapy, and the adoption of value-based care models.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9836&type=smp

Which Key Drivers Are Powering Growth In The Viscosupplementation Market?

The increasing occurrence of osteoarthritis is anticipated to drive the expansion of the viscosupplementation market in the future. Osteoarthritis is defined as a degenerative joint condition, a prevalent type of arthritis, where joints, particularly in the hips, knees, and hands, begin to deteriorate. Viscosupplementation therapy aids in alleviating pain and promoting smoother joint function through the direct injection of hyaluronic acid into the bone joints, thereby diminishing discomfort and enhancing joint performance. For example, data from the Centers for Disease Control and Prevention (CDC), a public health organization based in the USA, forecasts that by 2040, 78.4 million adults aged 18 years and older in the USA will be affected by arthritis. Consequently, the growing incidence of osteoarthritis is fueling the future development of the viscosupplementation market.

How Is The Global Viscosupplementation Market Structured By Key Segments?

The viscosupplementation market covered in this report is segmented –

1) By Type: Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation

2) By Source: Avian Origin, Non-Avian Origin

3) By Hyaluronic Acids: Standard Hyaluronic Acid, Stabilized Hyaluronic Acid

4) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis

5) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products, Non-Hyaluronic Acid Products

2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products

3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products, Combination Products

What Future-Focused Trends Are Anticipated In The Viscosupplementation Market?

Major companies operating in the viscosupplementation market are concentrating on developing innovative products such as resorbable, hyaluronic acid scaffolds to enhance joint lubrication, promote tissue regeneration, and provide long-lasting relief from osteoarthritis symptoms, thereby improving patient outcomes and expanding treatment options. A resorbable hyaluronic acid scaffold is a biocompatible, biodegradable structure made primarily from hyaluronic acid (HA), a naturally occurring polysaccharide found in connective tissues. Illustrating this, in May 2023, Anika Therapeutics, Inc., a US-based company that offers orthopedics, introduced Hyalofast, a single-stage, off-the-shelf, resorbable hyaluronic acid scaffold for cartilage repair. Hyalofast is designed to provide a hyaluronic acid-based solution aimed at joint preservation, potentially offering an alternative to more invasive surgical procedures.

Which Companies Hold A Competitive Edge In The Viscosupplementation Market?

Major companies operating in the viscosupplementation market include Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd., SingHealth Group

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/viscosupplementation-global-market-report

Which Region Is Expected To Lead The Viscosupplementation Market In The Next Few Years?

North America was the largest region in the viscosupplementation market in 2024. The regions covered in the viscosupplementation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9836&type=smp

Browse Through More Reports Similar to the Global Viscosupplementation Market 2025, By The Business Research Company

Wheat Protein Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wheat-protein-global-market-report

Egg Protein Powder Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/egg-protein-powder-global-market-report

Textured Soy Protein Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/textured-soy-protein-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795